Viridian Therapeutics, Inc. VRDN Operating Lease Liabilities (Current)
Operating Lease Liabilities (Current) at other companies
Other financials
Where this comes from
Reported directly by Viridian Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:OperatingLeaseLiabilityCurrent.
The official record: Viridian Therapeutics, Inc.’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about Viridian Therapeutics, Inc.'s operating lease liabilities (current).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Viridian Therapeutics, Inc.'s operating lease liabilities (current)?
- Viridian Therapeutics, Inc. (VRDN) reported operating lease liabilities (current) of $738K in Q1 2026.
- How has Viridian Therapeutics, Inc.'s operating lease liabilities (current) changed year-over-year?
- Viridian Therapeutics, Inc.'s operating lease liabilities (current) increased by 37.7% year-over-year, from $536K to $738K.
- What is the long-term trend for Viridian Therapeutics, Inc.'s operating lease liabilities (current)?
- Over 5 years (2020 to 2025), Viridian Therapeutics, Inc.'s operating lease liabilities (current) has grown at a 49.7% compound annual growth rate (CAGR), from $100K to $753K.
- What does operating lease liabilities (current) mean?
- The current portion of operating lease obligations due within one year, representing committed future lease payments under ASC 842.